title: Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation.
authors.forename: J A
authors.initials: JA
authors.lastname: Gutman
authors.forename: C T
authors.initials: CT
authors.lastname: Allen
authors.forename: D K
authors.initials: DK
authors.lastname: Madtes
authors.forename: J
authors.initials: J
authors.lastname: Schramm
authors.forename: C
authors.initials: C
authors.lastname: Delaney
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D036101:Cord Blood Stem Cell Transplantation; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011668:Pulmonary Veno-Occlusive Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin; D011239:Prednisolone